# Korea Pharma (South Korea)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/korea-pharma-south-korea/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 108.5 |
| Citations | 36,166 |
| City | Seoul |
| Country | KR |
| Description | Korea Pharma (South Korea) is a research organisation in Seoul, KR. OpenAlex records 1,265 works and 36,166 citations for it. 875 researchers list it as their most recent affiliation. |
| Homepage | http://www.koreapharma.co.kr/eng/ |
| OpenAlex ID | https://openalex.org/I4210095654 |
| Researchers | 875 |
| ROR ID | https://ror.org/00q650071 |
| Type | company |
| Works | 1,265 |

## University papers

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol](https://scholariq.org/papers/two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol/)
- [Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia](https://scholariq.org/papers/simvastatin-with-or-without-ezetimibe-in-familial-hypercholesterolemia/)
- [Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk](https://scholariq.org/papers/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse/)
- [Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients](https://scholariq.org/papers/bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins](https://scholariq.org/papers/association-of-ldl-cholesterol-non-hdl-cholesterol-and-apolipoprotein-b-levels/)
- [Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events](https://scholariq.org/papers/very-low-levels-of-atherogenic-lipoproteins-and-the-risk-for-cardiovascular/)
- [Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta‐analysis](https://scholariq.org/papers/treatment-of-periodontitis-improves-the-atherosclerotic-profile-a-systematic/)

## University top topics

Showing 8 of 25.

- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Probiotics and Fermented Foods](https://scholariq.org/topics/probiotics-and-fermented-foods/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.